Handelsavisen
prelaunch
Companies ›Healthcare ›VPT.V
VP
VPT.V — TSX Venture Advanced Medical Equipment & Technology

VentriPoint Diagnostics Ltd.

$0,12
Open in Charts → Attach watcher ⌖
— —
CAD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
21,6M CAD
P/E
—
EV / Rev
—
Div yield
—
Op margin
-5 037,6 %
ROE
165,0 %
Net margin
-5 169,2 %
Debt / equity
-0,55
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

VPT.V operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.

Business. VPT.V is a healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments and geographic presence are not disclosed. The company is primarily listed on the TSX Venture Exchange under the ticker VPT.V.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
165,0 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning VPT.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to VPT.V. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    VPT.V is a healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments and geographic presence are not disclosed. The company is primarily listed on the TSX Venture Exchange under the ticker VPT.V.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    The company's capital structure is highly leveraged, with total liabilities of CAD 36,399,000 and total equity of CAD -2,981,870, indicating a negative net worth. Liquidity is constrained, as evidenced by a current ratio of 0.14 and negative free cash flow of CAD -4,856,700. The company's market capitalization of CAD 23,457,398.88 is significantly lower than its enterprise value to revenue ratio of 263.02, suggesting a high valuation multiple relative to its revenue.

    Profitability is severely challenged, with a net loss of CAD -4,919,570 and an operating loss of CAD -4,794,240. The return on equity of 1.6498% is positive but extremely low, while the return on assets is negative at -7.4763%. These metrics fall well below the industry norms for profitability and returns, indicating significant underperformance.

    The company's revenue is concentrated in a single segment, as no segmental breakdown is provided in the available data. There is no geographic breakdown available, but the company's operations are likely concentrated in a single region given the lack of diversification in the financial data.

    The company's growth trajectory is negative, with a net loss and declining cash flow. The operating cash flow of CAD -3,386,200 and free cash flow of CAD -4,856,700 indicate a lack of operational cash generation. The company's revenue of CAD 95,170 is minimal, and there is no indication of growth in the current fiscal year.

    The company faces significant liquidity and solvency risks, with a negative net worth and high debt levels. The debt-to-equity ratio of -0.55 indicates that the company's liabilities exceed its equity. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the company's negative net cash position is a key flag.

    Recent events include a reported EPS of -1.20 CAD, indicating continued losses. There are no recent filings or transcripts available to provide additional context on the company's operations or strategic direction.

    Key takeaways
    • The company is operating at a significant loss with a net income of CAD -4,919,570.
    • The company's liquidity is constrained, with a current ratio of 0.14 and negative free cash flow.
    • The company's profitability is severely challenged, with a negative return on assets of -7.4763%.
    • The company's capital structure is highly leveraged, with total liabilities of CAD 36,399,000 and total equity of CAD -2,981,870.
    • The company's revenue is minimal at CAD 95,170, and there is no indication of growth.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,12
    Market cap
    $23.5M
    Enterprise valueⓘ
    $25.0M
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    -$3.0M
    Net cashⓘ
    -$1.6M
    Current ratioⓘ
    0.1
    Debt / equityⓘ
    -0.6
    ROAⓘ
    -7.5%
    ROEⓘ
    1.6%
    Cash conversionⓘ
    69.0%
    CapEx / revenueⓘ
    —
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-5 037,6 %Bottom quartile
    Net Margin-5 169,2 %Bottom quartile
    ROE165,0 %Best in class
    D/E-0,55Best in class
    Cash Conv0,69Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • VPT.V Market data — financials · 2026-05-29
    • VentriPoint Diagnostics Ltd Market data — analyst estimates · 2026-05-29

    Ownership & reference

    Leadership

    • George AdamsExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    VPT.VCanonical
    TSX Venture · CAD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage